Literature DB >> 8870047

Disruption of tolerance to the ataxic effect of ethanol by an extraneous stimulus.

S Siegel1, S J Larson.   

Abstract

According to a conditioning analysis, pharmacological conditional responses (CRs) contribute to tolerance. We previously reported that, as expected on the basis of this model, tolerance to the hypothermic effect of ethanol is attenuated by "external inhibition," for instance, by presentation of a novel stimulus (a strobe). However, results of more recent research indicate that novel stimuli augment the hypothermic effect of ethanol in rats receiving the drug for the first time. It is possible, therefore, that a novel stimulus apparently attenuates ethanol tolerance because it augments ethanol-hypothermia, rather than because it functions as an external inhibitor. Two experiments were designed to evaluate external inhibition of tolerance to another effect of ethanol-ataxia. Although the initial ataxic effect of the drug (unlike the hypothermic effect) is not enhanced by a novel stimulus, the stimulus reinstated ethanol-induced ataxia in tolerant rats. The results demonstrate external inhibition of ethanol tolerance in a preparation not confounded by the effects of the novel stimulus on initial responding to ethanol.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8870047     DOI: 10.1016/0091-3057(96)00074-3

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

1.  Context-Specific Tolerance and Pharmacological Changes in the Infralimbic Cortex-Nucleus Accumbens Shell Pathway Evoked by Ketamine.

Authors:  Gleice Kelli Silva-Cardoso; Manoel Jorge Nobre
Journal:  Neurochem Res       Date:  2021-03-30       Impact factor: 3.996

2.  An extinction cue reduces spontaneous recovery of ataxic ethanol tolerance in rats.

Authors:  Douglas C Brooks; Joanne M Vaughn; Andrew J Freeman; Amanda M Woods
Journal:  Psychopharmacology (Berl)       Date:  2004-05-26       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.